Voyager Therapeutics (NASDAQ:VYGR) Raised to Strong-Buy at Leerink Partnrs
Leerink Partnrs upgraded shares of Voyager Therapeutics (NASDAQ:VYGR – Free Report) to a strong-buy rating in a research note issued to investors on Wednesday, Zacks.com reports. Leerink Partnrs also issued estimates for Voyager Therapeutics’ Q3 2024 earnings at ($0.08) EPS, Q4 2024 earnings at ($0.08) EPS, FY2024 earnings at ($0.44) EPS, FY2025 earnings at ($0.41) […]
More Stories
Nexo Price Tops $1.02 on Exchanges (NEXO)
Nexo (NEXO) traded 1.7% higher against the dollar during the twenty-four hour period ending at 14:00 PM Eastern on October...
Alta Wealth Advisors LLC Sells 223 Shares of Target Co. (NYSE:TGT)
Alta Wealth Advisors LLC lowered its stake in shares of Target Co. (NYSE:TGT – Free Report) by 14.8% in the...
Embree Financial Group Acquires 2,611 Shares of iShares Core S&P Small-Cap ETF (NYSEARCA:IJR)
Embree Financial Group grew its holdings in iShares Core S&P Small-Cap ETF (NYSEARCA:IJR – Free Report) by 2.1% in the...
Embree Financial Group Purchases 50 Shares of Vanguard Dividend Appreciation ETF (NYSEARCA:VIG)
Embree Financial Group grew its position in shares of Vanguard Dividend Appreciation ETF (NYSEARCA:VIG – Free Report) by 0.3% in...
AA Financial Advisors LLC Raises Stock Position in Visa Inc. (NYSE:V)
AA Financial Advisors LLC lifted its position in Visa Inc. (NYSE:V – Free Report) by 1.9% in the third quarter,...
Baron Financial Group LLC Cuts Stake in SPDR Gold Shares (NYSEARCA:GLD)
Baron Financial Group LLC trimmed its position in SPDR Gold Shares (NYSEARCA:GLD – Free Report) by 3.4% in the third...